StonvexLoading…
StonvexStonvexStonvexCore line items from MDLZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $10.08B | $38.54B | $28.04B | $18.30B |
Operating Income | $808.00M | $3.55B | $2.60B | $1.85B |
Net Income | $560.00M | $2.45B | $1.79B | $1.04B |
EPS (Diluted) | $0.44 | $1.89 | $1.37 | $0.80 |
Total Assets | $71.12B | $71.49B | $71.36B | $71.02B |
Total Liabilities | $45.32B | $45.60B | $45.13B | $44.77B |
Cash & Equivalents | $1.63B | $2.19B | $1.47B | $1.59B |
Free Cash Flow OCF − CapEx | $155.00M | $3.23B | $1.24B | $818.00M |
Shares Outstanding | 1.29B | 1.30B | 1.30B | 1.30B |